We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

SARSTEDT AG+CO KG

Sarstedt provides laboratory and medical equipments, and develops, manufactures and sells equipment and consumables i... read more Featured Products: More products

Download Mobile App




Manual Aspiration by Monovette Reduces Hemolytic Sampling

By LabMedica International staff writers
Posted on 18 Aug 2021
Hemolytic blood samples are the number one cause for specimen rejection at emergency departments (ED). More...
Triggered by unsuitable blood sampling material or incorrect handling and a related strong vacuum force, hemolytic samples often must be retaken.

Hemolysis refers to the release of hemoglobin and other intracellular components into the surrounding plasma due to the ruptured cell membrane of erythrocytes. The root cause of hemolysis in vitro is an improper sample drawing or, more specifically, an evolving strong vacuum force.

Clinical Laboratorians at the HFR Fribourg-Hôpital Cantonal (Villars-sur-Glâne, Switzerland) conducted a head-to-head study between January and April 2019. In the first eight weeks, all specimens were collected using BD Vacutainer Lithium-Heparin Gel tubes (Vacutainer, Becton, Dickinson and Company, Franklin Lakes, NJ, USA), in the second eight weeks, blood was taken using S-Monovette Lithium-Heparin Gel tubes (SARSTEDT AG, Nümbrecht, Germany) in aspiration mode. Specimens were categorized into five classes (0–30, 31–50, 51–75, 76–100, and 101+ mg/dL of cell-free hemoglobin) and for the statistical analyses, all samples exceeding 30 mg/dL were classified as hemolytic.

All blood samples from the emergency department were evaluated using a Cobas 6000, (Roche Diagnostics, Rotkreuz, Switzerland) a state-of-the-art analyzing system, and their Hemolysis Index (HI 1 = 1 mg of free cell hemoglobin in 1 dL blood plasma) was determined. Data were collected on 4,794 blood specimens (Vacutainer: 2,634 samples, S-Monovette: 2,160 samples).

The scientists reported that overall, 11.3 % of samples were rated as hemolytic because their concentration of hemolysis exceeded 30 mg/dL. This proportion differed considerably between specimens drawn by Vacutainer (17.0 %) and S-Monovette (4.3 %), meaning that, in proportion, there were four times as many hemolytic samples when using Vacutainer. While the percentage of non-hemolytic samples (HI of 0–30 mg/dl) was substantially higher for specimens drawn by S-Monovette (95.7 %) than Vacutainer (83.0 %), the opposite was true for all HI categories above 30 mg/dl.

The authors concluded that regarding hemolysis rates, a slow manual aspiration using S-Monovette was superior to vacuum tubes with predefined filling volumes, as demonstrated in the setting of their ED, which has important practical implications. This blood sampling process could be highly beneficial, not only from a financial point of view, but also with regards to reducing unnecessary tasks and stress for nursing staff and improving patient outcome overall. The study was published on July 28, 2021 in the journal Practical Laboratory Medicine.

Related Links:
HFR Fribourg-Hôpital Cantonal
Becton, Dickinson and Company
SARSTEDT AG
Roche Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Slide Scanner System
NanoZoomer S540MD
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.